The research group of Dal Piaz and Giovannoni synthesized a series of tricyclic pyrazolopyrimidopyridazinones of general formula XXII (Figure 33) with potent and selective PDE5 inhibition properties as potential agents for the treatment of erectile dysfunction. Here, PDE5A is linked to erectile dysfunction.